National News
New Legislation Aims to Enhance Efficiency in 340B Drug Pricing Program
Content Files PDF XML TEXT Metadata download Descriptive Metadata (MODS) Preservation Metadata (PREMIS) All Content and Metadata files, including granules ZIP
Last updated:
Key points
- H.R. 9599 is proposed legislation aimed at improving the 340B Drug Pricing Program.
- The bill focuses on enhancing operational efficiency and controls within the program.
- Local healthcare providers may be significantly affected by these changes in drug pricing and access.
NewsWK — A new piece of legislation, known as H.R. 9599, has been introduced to strengthen controls and improve the efficiency of the 340B Drug Pricing Program. This program is designed to help healthcare providers serving low-income and uninsured patients access affordable medications.
The bill seeks to address various operational challenges faced by the 340B program, ensuring that eligible entities can maximize their resources to better serve their communities. By implementing stricter controls and updated requirements, the legislation aims to enhance the overall effectiveness of the program.
As healthcare continues to be a pressing issue for many Americans, local healthcare providers and policymakers will likely monitor the progress of this legislation closely, given its potential impact on drug pricing and access to care.
Based on reporting originally published by GovInfo (U.S. GPO). Read the original story.
